Links

Links to things that I've found interesting, sometimes with commentary.

Currently a combination of:

I wrote a post about how this system works and there is also an RSS feed available.

Beyond Microblogging: AT Protocol for Building Unique Social Apps

bmannconsulting.com

The bottom line is joy: making apps should be fun, they should bring joy to users – including the confidence that the data is in their own account – and we should have a large variety of apps, from small, silly to big, serious. And beyond microblogging is where all the good stuff is.

Great overview by Boris. I learned a lot and was oriented to the landscape of things that AT protocol can be. My fediverse use has been limited to Mastodon thus far, so this was a way to see how wide AT can be.

Wayback

wayback.freedesktop.org

Wayback is an X11 compatibility layer which allows for running full X11 desktop environments using Wayland components. It is intended to eventually replace the classic X.Org server, thus reducing maintenance burden of X11 applications.

Newsradar: a work-in-progress newsreader for the Macintosh

jonmsterling.com

I understand that many people want to use the Web as a platform to make money or become famous; but I am equally within my rights to wish to use the Web to communicate ideas, create and consume educational materials, and socialise with my friends and family. It is a good thing rather than a bad thing to create tools that explicitly do not support the kind of fame-seeking behaviour that has turned the Web into a hellscape of scams, advertising, shilling, gambling, and exploitation. I do not judge the way any person chooses makes a living, but I know what I do and do not want in my life.

Count me in.

FDA approves new HIV drug offering 100% protection

newatlas.com

“This is not just a scientific breakthrough – it’s a game-changer for HIV/AIDS,” said Peter Sands, Executive Director of the Global Fund. “For the first time, we have a tool that can fundamentally change the trajectory of the HIV epidemic – but only if we get it to the people who need it most. Our ambition is to reach two million people with long-acting PrEP. But we can only do that if the world steps up with the resources required.